Legato Capital Management LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1442641
San Francisco, CA
Position in BMY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,271,255
-$639,575 QoQ
Shares Held
74,128
-8.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#589
of 2,506 holders
Holding Since
Dec 2022
15 quarters on record
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $15,619,590 across 5 Drug Manufacturers - General names. BMY ranks #1 (27.3% of the industry book) .
All Filings in BMY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,271,255 | 74,128 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $4,910,830 | 80,970 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $5,371,560 | 99,584 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $1,900,784 | 42,146 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $1,950,938 | 42,146 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,570,484 | 42,146 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $2,383,777 | 42,146 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $2,180,634 | 42,146 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $1,505,753 | 36,257 | Shares | Other | 2024-07-26 | |
| 2024-03-31 | $2,867,194 | 52,871 | Shares | Other | 2024-04-15 | |
| 2023-12-31 | $2,235,730 | 43,573 | Shares | Other | 2024-01-16 | |
| 2023-09-30 | $2,528,976 | 43,573 | Shares | Other | 2023-10-12 | |
| 2023-06-30 | $2,786,493 | 43,573 | Shares | Other | 2023-08-18 | |
| 2023-03-31 | $2,564,816 | 37,005 | Shares | Other | 2023-05-25 | |
| 2022-12-31 | $2,320,675 | 32,254 | Shares | Other | 2023-02-01 | |
| No filing history on record for this holder in this stock. | ||||||